Isabel Olson

Isabel Olson is a Principal Scientist in Formulation and Process Development at Gilead Sciences, where they lead the development of small molecule formulation and process optimization for oral solid dosage forms. Previously, they held the position of Senior Research Scientist I at Gilead Sciences and contributed to the registration of toxicology formulations through regulatory submissions. Isabel began their career at Roswell Park Cancer Institute, conducting research on the anti-cancerous properties of Vitamin D, which led to a publication. They also served as an Adjunct Instructor at New York University, teaching undergraduate chemistry courses. Isabel holds a PhD in Physical Chemistry from New York University, as well as a Master's in Secondary Education from Hobart and William Smith Colleges.